
    
      This study was a 4 weeks, randomized, double-blind, placebo-controlled trial. Forty-two
      subjects with IFG or type 2 diabetes were randomly allocated to 2 groups to consume placebo
      or FRG three times per day for 4 weeks. Fasting and postprandial glucose profiles during meal
      tolerance test were assessed before and after the intervention.
    
  